Cardiovascular protective effects of adjunctive alternative medicine (Salvia miltiorrhiza and Pueraria lobata) in high-risk hypertension

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Woo, K S ^a   Yip, Thomas W C ^b   Chook, Ping ^a   Kwong, S K ^c   Szeto, C C ^a   Li, June K Y ^b   Yu, Alex W Y ^c   Cheng, William K F ^a   Chan, Thomas Y K ^a   Fung, K P ^a   Leung, P C ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b YAN CHAI HOSPITAL   (Hong Kong)

^c Alice Ho Miu Ling Nethersole Hopsital ^*  (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR AGENT; CREATININE; GLUCOSE; HEMOGLOBIN A1C; HERBACEOUS AGENT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ALTERNATIVE MEDICINE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; BRACHIAL ARTERY; CAROTID ARTERY; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOUBLE BLIND PROCEDURE; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HEART RATE; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LEUKOCYTE; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PUERARIA LOBATA; RANDOMIZED CONTROLLED TRIAL; SALVIA MILTIORRHIZA; SIDE EFFECT; THROMBOCYTE; UNSPECIFIED SIDE EFFECT;

EID: 84875428385     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/132912     Document Type: Article

References (48)

1. Murray C. J. L., Lopez A. D., Mortality by cause for eight regions of the world: Global Burden of Disease Study. The Lancet 1997 349 9061 1269 1276 2-s2.0-0030983708 (Pubitemid 27192468)
2. Kearney P. M., Whelton M., Reynolds K., Muntner P., Whelton P. K., He J., Global burden of hypertension: analysis of worldwide data. The Lancet 2005 365 9455 217 223 2-s2.0-12344282783 10.1016/S0140-6736(05)17741-1 (Pubitemid 40138015)
3. Koren M. J., Devereux R. B., Casale P. N., Savage D. D., Laragh J. H., Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Annals of Internal Medicine 1991 114 5 345 352 2-s2.0-0026092229
4. National Kidney Foundation, K/DOQI clinical practice guidelines on hypertension and antihypertensive agents in chronic kidney disease. American Journal of Kidney Diseases 2004 43 supplement 1 S1 S290
5. Almgren T., Wilhelmsen L., Samuelsson O., Himmelmann A., Rosengren A., Andersson O. K., Diabetes in treated hypertension is common and carries a high cardiovascular risk: results from a 28-year follow-up. Journal of Hypertension 2007 25 6 1311 1317 2-s2.0-34250345162 10.1097/HJH.0b013e328122dd58 (Pubitemid 46918812)
6. Mancia G., de Backer G., Dominiczak A., 2007 Guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal 2007 28 1462 1536
7. Ji X. Y., Tan B. K. H., Zhu Y. Z., Salvia miltiorrhiza and ischemic diseases. Acta Pharmacologica Sinica 2000 21 12 1089 1094 2-s2.0-0034534954
8. Tam W. Y., Chook P., Qiao M., Chan L. T., Chan T. Y. K., Poon Y. K., Fung K. P., Leung P. C., Woo K. S., The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhiza and Pueraria lobata) on vascular function and structure in coronary patients. Journal of Alternative and Complementary Medicine 2009 15 4 415 421 2-s2.0-65549153251 10.1089/acm.2008.0400
9. Jiang R. W., Lau K. M., Lam H. M., Yam W. S., Leung L. K., Choi K. L., Waye M. M. Y., Mak T. C. W., Woo K. S., Fung K. P., A comparative study on aqueous root extracts of Pueraria thomsonii and Pueraria lobata by antioxidant assay and HPLC fingerprint analysis. Journal of Ethnopharmacology 2005 96 1-2 133 138 2-s2.0-20844446133 10.1016/j.jep.2004.08.029 (Pubitemid 39575042)
10. Fung K. P., Zeng L. H., Wu J., Wong H. N. C., Lee C. M., Hon P. M., Chang H. M., Wu T. W., Demonstration of the myocardial salvage effect of lithospermic acid B isolated from the aqueous extract of Salvia miltiorrhiza. Life Sciences 1993 52 22 PL239 PL244 2-s2.0-0027456480 10.1016/0024-3205(93)90471-E
11. Jiang R. W., Lau K. M., Hon P. M., Mak T. C. W., Woo K. S., Fung K. P., Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza. Current Medicinal Chemistry 2005 12 2 237 246 2-s2.0-11844260060 (Pubitemid 40089836)
12. Sun Y., Shaw P. C., Fung K. P., Molecular authentication of Radix Puerariae Lobatae and Radix Puerariae Thomsonii by ITS and 5S rRNA spacer sequencing. Biological and Pharmaceutical Bulletin 2007 30 1 173 175 2-s2.0-33846085648 10.1248/bpb.30.173 (Pubitemid 46066341)
13. Celermajer D. S., Sorensen K. E., Gooch V. M., Spiegelhalter D. J., Miller O. I., Sullivan I. D., Lloyd J. K., Deanfield J. E., Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. The Lancet 1992 340 8828 1111 1115 2-s2.0-0026478022 10.1016/0140-6736(92)93147-F
14. Deanfield J., Donald A., Ferri C., Giannattasio C., Halcox J., Halligan S., Lerman A., Mancia G., Oliver J. J., Pessina A. C., Rizzoni D., Rossi G. P., Salvetti A., Schiffrin E. L., Taddei S., Webb D. J., Endothelial function and dysfunction. Part I: methodological issues for assessment in the different vascular beds: a statement by the working group on endothelin and endothelial factors of the European society of hypertension. Journal of Hypertension 2005 23 1 7 17 2-s2.0-19944430327 10.1097/00004872-200501000-00004 (Pubitemid 40128972)
15. Anderson T. J., Uehata A., Gerhard M. D., Meredith I. T., Knab S., Delagrange D., Lieberman E. H., Ganz P., Creager M. A., Yeung A. C., Selwyn A. P., Close relation of endothelial function in the human coronary and peripheral circulations. Journal of the American College of Cardiology 1995 26 5 1235 1241 2-s2.0-0028784709 10.1016/0735-1097(95)00327-4
16. Teragawa H., Ueda K., Matsuda K., Kimura M., Higashi Y., Oshima T., Yoshizumi M., Chayama K., Relationship between endothelial function in the coronary and brachial arteries. Clinical Cardiology 2005 28 10 460 466 2-s2.0-26444595656 (Pubitemid 41434272)
17. Schroeder S., Enderle M. D., Ossen R., Meisner C., Baumbach A., Pfohl M., Herdeg C., Oberhoff M., Haering H. U., Karsch K. R., Noninvasive determination of endothelium-mediated vasodilation as a screening test for coronary artery disease: pilot study to assess the predictive value in comparison with angina pectoris, exercise electrocardiography, and myocardial perfusion imaging. American Heart Journal 1999 138 4 731 739 2-s2.0-0032886689 10.1016/S0002- 8703(99)70189-4 (Pubitemid 29471049)
18. Sorensen K. E., Celermajer D. S., Spiegelhalter D. J., Georgakopoulos D., Robinson J., Thomas O., Deanfield J. E., Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility. British Heart Journal 1995 74 3 247 253 2-s2.0-0029117715
19. Woo K. S., Chook P., Lolin Y. I., Sanderson J. E., Metreweli C., Celermajer D. S., Folic acid improves arterial endothelial function in adults with hyperhomocysteinaemia. American College of Cardiology Foundation 1999 34 2002 2006 10.1016/S0735-1097(99)00469-6 (Pubitemid 30002657)
20. Woo K. S., Chook P., Yu C. W., Sung R. Y. T., Qiao M., Leung S. S. F., Lam C. W. K., Metreweli C., Celermajer D. S., Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004 109 16 1981 1986 2-s2.0-2142767317 10.1161/01.CIR.0000126599.47470.BE (Pubitemid 38544488)
21. Salonen R., Salonen J. T., Determinants of carotid intima-media thickness: a population-based ultrasonography study in Eastern Finnish men. Journal of Internal Medicine 1991 229 3 225 231 2-s2.0-0025980304
22. Bots M. L., Hoes A. W., Koudstaal P. J., Hofman A., Grobbee D. E., Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation 1997 96 5 1432 1437 2-s2.0-0030826182 (Pubitemid 27375333)
23. Woo K. S., Chook P., Raitakari O. T., McQuillan B., Feng J. Z., Celermajer D. S., Westernization of Chinese adults and increased subclinical atherosclerosis. Arteriosclerosis, Thrombosis, and Vascular Biology 1999 19 10 2487 2493 2-s2.0-0032849732 (Pubitemid 29477851)
24. Hochberg Y., A sharper bonferroni procedure for multiple tests of significance. Biometrika 1988 75 4 800 802 2-s2.0-33645762226 10.1093/biomet/75.4.800
25. Behrendt D., Ganz P., Endothelial function: from vascular biology to clinical applications. American Journal of Cardiology 2002 90 10 40L 48L 2-s2.0-0037153047 (Pubitemid 35379905)
26. O'Leary D. H., Polak J. F., Kronmal R. A., Manolio T. A., Burke G. L., Wolfson S. K., Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. The New England Journal of Medicine 1999 340 1 14 22 2-s2.0-0033531215 10.1056/NEJM199901073400103 (Pubitemid 29024679)
27. Lorenz M. W., Markus H. S., Bots M. L., Rosvall M., Sitzer M., Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis. Circulation 2007 115 4 459 467 2-s2.0-33846609195 10.1161/CIRCULATIONAHA.106.628875 (Pubitemid 46184197)
28. Libby P., Ridker P. M., Hansson G. K., Inflammation in Atherosclerosis: from pathophysiology to practice. Journal of the American College of Cardiology 2009 54 23 2129 2138 2-s2.0-70450189795 10.1016/j.jacc.2009.09.009
29. Zhang K. Q., Bao Y., Wu P., Rosen R. T., Ho C. T., Antioxidative components of tanshen (Salvia miltiorrhiza Bung). Journal of Agricultural and Food Chemistry 1990 38 5 1194 1197 2-s2.0-0000134154
30. Lei X. L., Chiou G. C., Studies on cardiovascular actions of Salvia miltiorrhiza. The American journal of Chinese medicine 1986 14 1-2 26 32 2-s2.0-0022612112
31. Zhou L., Zuo Z., Chow M. S. S., Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. Journal of Clinical Pharmacology 2005 45 12 1345 1359 2-s2.0-27844511101 10.1177/0091270005282630 (Pubitemid 41643896)
32. Cheng T. O., Cardiovascular effects of Danshen. International Journal of Cardiology 2007 121 1 9 22 2-s2.0-34548079309 10.1016/j.ijcard.2007.01.004 (Pubitemid 47287779)
33. Fan L. L., O'Keefe D. D., Powell W. J., Effect of puerarin on regional myocardial blood flow and cardiac hemodynamics in dogs with acute myocardial ischemia. Yao Xue Xue Bao 1984 19 11 801 807 2-s2.0-0041837118
34. Zhang G., Fang S., Antioxidation of Pueraria lobata isoflavones (PLIs). Zhong yao Cai 1997 20 7 358 360 2-s2.0-0242337747
35. Sieveking D. P., Woo K. S., Fung K. P., Lundman P., Nakhla S., Celermajer D. S., Chinese herbs danshen and gegen modulate key early atherogenic events in vitro. International Journal of Cardiology 2005 105 1 40 45 2-s2.0-26044433068 10.1016/j.ijcard.2004.10.052 (Pubitemid 41408528)
36. +cells, metabolic syndrome, and cardiovascular risk. European Heart Journal 2006 27 2247 2255 10.1093/eurheartj/ehl198 (Pubitemid 44412842)
37. Werner N., Kosiol S., Schiegl T., Ahlers P., Walenta K., Link A., Böhm M., Nickenig G., Circulating endothelial progenitor cells and cardiovascular outcomes. The New England Journal of Medicine 2005 353 10 999 1007 2-s2.0-24344442873 10.1056/NEJMoa043814 (Pubitemid 41262334)
38. Yip T. W. C., Wong C. K., Chook P., Lun S. W. M., Kwong S. K., Lam C. W. K., Fung K. P., Leung P. C., Woo K. S., The impact of adjunctive danshen-gegen treatment on endothelial progenitor cell activity in hypertensive subjects. The Journal of the Hong Kong College of Cardiology 2008 16 1. abstract 18
39. Chan K., Lo A. C. T., Yeung J. H. K., Woo K. S., The effects of Danshen (Salvia miltiorrhiza) on warfarin pharmacodynamics and pharmacokinetics of warfarin enantiomers in rats. Journal of Pharmacy and Pharmacology 1995 47 5 402 406 2-s2.0-0029025569
40. Gupta D., Jalali M., Wells A., Dasgupta A., Drug-herb interactions: unexpected suppression of free Danshen concentrations by salicylate. Journal of Clinical Laboratory Analysis 2002 16 6 290 294 2-s2.0-0036441113 10.1002/jcla.10057 (Pubitemid 35397103)
41. Chan T. Y. K., Interaction between warfarin and danshen (Salvia miltiorrhiza). Annals of Pharmacotherapy 2001 35 4 501 504 2-s2.0-0035091233 (Pubitemid 32260218)
42. Tam L. S., Chan T. Y. K., Leung W. K., Critchley J. A. J. H., Warfarin interactions with Chinese traditional medicines: Danshen and methyl salicylate medicated oil. Australian and New Zealand Journal of Medicine 1995 25 3 258 2-s2.0-0029101910
43. Jinping Q., Peiling H., Yawei L., Abliz Z., Effects of the aqueous extract from Salvia miltiorrhiza Bge on the pharmacokinetics of diazepam and on liver microsomal cytochrome P450 enzyme activity in rats. Journal of Pharmacy and Pharmacology 2003 55 8 1163 1167 2-s2.0-0041524153 10.1211/0022357021602 (Pubitemid 36998659)
44. Cheng T. O., Herbal interactions with cardiac drugs. Archives of Internal Medicine 2000 160 6 870 871 2-s2.0-0034719879
45. Kang D. G., Yun Y. G., Ryoo J. H., Lee H. S., Anti-hypertensive effect of water extract of Danshen on renovascular hypertension through inhibition of the renin angiotensin system. American Journal of Chinese Medicine 2002 30 1 87 93 2-s2.0-0036047983 10.1142/S0192415X02000107 (Pubitemid 41758924)
46. Sun J., Huang S. H., Tan B. K. H., Whiteman M., Zhu Y. C., Wu Y. J., Ng Y., Duan W., Zhu Y. Z., Effects of purified herbal extract of Salvia miltiorrhiza on ischemic rat myocardium after acute myocardial infarction. Life Sciences 2005 76 24 2849 2860 2-s2.0-16244371762 10.1016/j.lfs.2004.11.016 (Pubitemid 40460330)
47. Wang G., Wang L., Xiong Z. Y., Mao B., Li T. Q., Compound salvia pellet, a traditional Chinese medicine, for the treatment of chronic stable angina pectoris compared with nitrates: a meta-analysis. Medical Science Monitor 2006 12 1 SR1 SR7 2-s2.0-30944446397 (Pubitemid 43116663)
48. Cheng T. O., Danshen: what every cardiologist should know about this Chinese herbal drug. International Journal of Cardiology 2006 110 3 411 412 2-s2.0-33744804557 10.1016/j.ijcard.2005.08.069 (Pubitemid 43831220)